Vaccine for stomach flu may be possible, research shows

Every year, millions of people are infected with noroviruses - commonly called “stomach flu” – often resulting in up to 72 hours of vomiting and diarrhea. While most people recover in a few days, the symptoms can lead to dehydration and - in rare cases, especially among the elderly and infants - death.

Now, researchers at the University of North Carolina School of Public Health have discovered that the virus mutates genetically, similar to the virus that causes influenza. And, like flu, a vaccine could be possible.

“One of the mysteries of medicine has been why do they keep infecting people when you’d think we’d be developing immunity,” said Lisa Lindesmith, one of the lead authors of the study, “Mechanisms of GII.4 Norovirus Persistence in Human Populations,” published today in the online medical journal PLoS Medicine. “What we’ve found is that the GII.4 arm [of the noroviruses] keeps changing. Whenever we’re seeing big outbreaks of norovirus, we’re also seeing genetic changes in the virus.”

Noroviruses are the leading cause of viral acute gastroenteritis. They are highly contagious, often causing epidemic outbreaks in families and communities, on cruise ships, in hospitals and in assisted living facilities. The viruses are especially hard on the elderly – in 2006, 19 deaths were associated with norovirus acute gastroenteritis in long-term care facilities in the United States. Often, infection can mean many miserable hours, with time lost from work, school and other activities. There is no treatment to stop the infection.

The virus, first isolated from an outbreak in an elementary school in Norwalk, Ohio, in 1968, is common worldwide. The researchers analyzed the relationship among the sequences of certain genes encoding the GII.4 norovirus strains that have been isolated over the past 20 years. They found that the virus evolved irregularly, and when new strains emerged, they often cause epidemic outbreaks.

Authors from UNC include Lindesmith, an epidemiology research specialist in the School of Public Health; Eric Donaldson and Anna LoBue, both doctoral students and research assistants in microbiology and immunology in the UNC School of Medicine; Jennifer Cannon, doctoral student in environmental sciences and engineering; and Ralph Baric, Ph.D., a professor in the School of Public Health’s epidemiology department and in the School of Medicine’s microbiology and immunology department. Authors from the Centers for Disease Control and Prevention include Du-ping Zheng, Ph.D. and Jan Vinje, Ph.D., head of the CDC’s National Calicivirus Laboratory.

“Noroviruses are very contagious,” Lindesmith said. “It may only take one or two viral particles to become infected. Good hand washing is critical when the virus is present. A vaccine may someday have an important role, too, especially among the elderly and other people particularly vulnerable to the effects of the illness.”

Source: University of North Carolina at Chapel Hill

Related stories:

Researchers discover primary sensor that detects stomach viruses
Scientists at Washington University School of Medicine in St. Louis have identified the primary immune sensor that detects the presence of stomach viruses in the body. They show that the sensor – a protein called MDA-5 – triggers an immune response that revs up the body's defenses to fight off the infection. This knowledge may help develop a treatment that prevents or reduces infection, the researchers suggest in their study, published July 18th in the open-access journal PLoS Pathogens.
Norovirus suspected in school outbreak
A highly contagious stomach virus sickened more than 100 students and staff at a suburban Chicago high school this week.
Norwalk virus: 'Cruise ship' illness challenging and costly to hospitals, too
A review of measures taken to address a 2004 outbreak of the highly infectious Norwalk virus at The Johns Hopkins Hospital has provided the first solid documentation of expenses and efforts in the United States to stop the infection from spreading among patients, staff and visitors. Total hospital costs for the three-month outbreak - including extra cleaning supplies, staff sick leave, diagnostic tests, replacement staff, and salaries and lost revenue from closed beds - were estimated at more than $650,000.
Researchers use mass spectrometry to detect norovirus particles
Scientists have used mass spectrometry for decades to determine the chemical composition of samples but rarely has it been used to identify viruses, and never in complex environmental samples. Researchers at the Johns Hopkins Bloomberg School of Public Health recently demonstrated that proteomic mass spectrometry has the potential to be applied for this purpose. Using a two-step process, researchers successfully separated, purified and concentrated a norovirus surrogate from a clinical sample within a few hours. Nanospray mass spectrometry was used to demonstrate the feasibility of detecting norovirus particles in the purified concentrates.
Study shows no connection between measles, mumps, rubella (MMR) vaccine and autism
In a case-control study, the presence of measles virus RNA was no more likely in children with autism and GI disturbances than in children with only GI disturbances. Furthermore, GI symptom and autism onset were unrelated to MMR vaccine timing.
Americans adopting HIV-positive kids from Ethiopia
(AP) -- Solomon Henderson inherited just three things from his birth parents, who left him at an Ethiopian orphanage when he was 1 year old: a picture of Jesus, a plastic crucifix and HIV.
Flu shot does not reduce risk of death
The widely-held perception that the influenza vaccination reduces overall mortality risk in the elderly does not withstand careful scrutiny, according to researchers in Alberta. The vaccine does confer protection against specific strains of influenza, but its overall benefit appears to have been exaggerated by a number of observational studies that found a very large reduction in all-cause mortality among elderly patients who had been vaccinated.
First gene associated with dry macular degeneration found
In a study that underscores the important role that individual genetic profiles will play in the development of new therapies for disease, a multi-institutional research team – led by Kang Zhang, MD, PhD professor of ophthalmology and human genetics at Shiley Eye Center at the University of California, San Diego, School of Medicine – has made two important discoveries related to age-related macular degeneration (AMD), the leading cause of blindness in adults over the age of 60.

News discussion:

Medicine & Health news